EUVIMEDEUVIMED entdecken
Open Access

Inositol biosynthesis is inversely regulated by glycolytic activity

Chisom J Onu, Michael Adu, Dania Jabbar, Emmanuel Ezumel, Michael W Schmidtke, Adolfo Saiardi, Miriam L Greenberg

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2026-08 · 1871 (6) · 159752

DOI: 10.1016/j.bbalip.2026.159752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2026-08. Verfasst von Chisom J Onu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Wayne State University, Detroit, MI, USA. Hauptthemen laut MEDLINE: Inositol, Glycolysis, Saccharomyces cerevisiae. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, UK Research and Innovation Medical Research Council, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inositol is an essential metabolite required for membrane biogenesis, cell signaling and trafficking, and gene expression. Its importance is underscored by the fact that inositol depletion leads to death in eukaryotic cells ranging from yeast to human. Perturbation of inositol homeostasis is implicated in numerous human disorders. In yeast, inositol is synthesized de novo from glucose-6-phosphate (G-6-P) through a two-step pathway controlled by the rate-limiting enzyme myo-inositol phosphate synthase (MIPS), encoded by INO1. INO1 expression is tightly controlled by the Henry regulatory circuit in response to inositol and by the Reg1-Snf1 pathway in response to glucose. As both inositol synthesis and glycolysis utilize the same precursor, G-6-P, the current study tested the hypothesis that inositol synthesis is regulated by glycolytic activity. Genetic and pharmacological approaches were used to alter glycolysis. Inositol synthesis was determined by liquid chromatography mass spectrometry analysis of [U-13C]-glucose incorporation into inositol and by assaying INO1 mRNA and MIPS protein expression. In rho0 cells and wild type cells treated with the electron transport inhibitor potassium cyanide, both of which exhibit increased glycolytic activity, inositol levels were reduced by 47.5% and 57.9%, respectively, compared to controls. INO1 mRNA and MIPS protein levels were also decreased in these cells. The effect of downregulation of glycolysis was determined using the humanized yeast strain HHK2, which expresses a decreased rate of glycolysis due to the less active human hexokinase. Consistent with our hypothesis, HHK2 cells exhibited a 41.5% increase in inositol synthesis. Dysregulation of inositol synthesis did not affect glycolysis. These results identify altered glycolytic activity as a mechanism of inositol regulation and demonstrate the role of metabolic crosstalk in controlling these biochemical pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InositolGlycolysisSaccharomyces cerevisiaeMyo-Inositol-1-Phosphate SynthaseSaccharomyces cerevisiae ProteinsHumansGlucose-6-PhosphateGlucose

Stichwörter der Autor:innen

Dihydroxyacetone phosphate (DHAP)Glucose-6-phosphate (G-6-P)GlycolysisINO1InositolMyo-inositol phosphate synthase (MIPS)

Substanzen

InositolMyo-Inositol-1-Phosphate SynthaseSaccharomyces cerevisiae ProteinsINO1 protein, S cerevisiaeGlucose-6-PhosphateGlucose

Autor:innen und Institutionen

  • Department of Biological Sciences, Wayne State University, Detroit, MI, USA.
  • Laboratory for Molecular Cell Biology, University College London, London, England, WC1E 6BT, GB, United Kingdom of Great Britain and Northern Ireland.
  • Department of Biological Sciences, Wayne State University, Detroit, MI, USA. Electronic address: mgreenberg@wayne.edu.

Förderung

  • NIGMS NIH HHS
  • UK Research and Innovation Medical Research Council
  • National Institutes of Health
  • UK Research and Innovation
  • National Institute of General Medical Sciences

Zitieren

APA

Onu, C. J., Adu, M., Jabbar, D., Ezumel, E., Schmidtke, M. W., Saiardi, A., & Greenberg, M. L. (2026). Inositol biosynthesis is inversely regulated by glycolytic activity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1871(6), 159752. https://doi.org/10.1016/j.bbalip.2026.159752

Vancouver

Onu CJ, Adu M, Jabbar D, Ezumel E, Schmidtke MW, Saiardi A, et al. Inositol biosynthesis is inversely regulated by glycolytic activity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2026;1871(6):159752. doi:10.1016/j.bbalip.2026.159752

BibTeX
@article{Onu2026,
  author = {Onu, Chisom J and Adu, Michael and Jabbar, Dania and Ezumel, Emmanuel and Schmidtke, Michael W and Saiardi, Adolfo and Greenberg, Miriam L},
  title = {Inositol biosynthesis is inversely regulated by glycolytic activity},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids},
  year = {2026},
  volume = {1871},
  number = {6},
  pages = {159752},
  doi = {10.1016/j.bbalip.2026.159752}
}
Kostenlos starten →